HRT May Get Revised Label; Costco to Sell No-Insurance Ozempic; CGM Without Diabetes

(MedPage Today) — The FDA is considering changing the black box warning on hormone replacement therapy (HRT) products, said Commissioner Marty Makary, MD, MPH. (CNN)
Among men with diabetes and hypogonadism, use of testosterone therapy was associated…